Login / Signup

Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective Study.

Alessio AmatuGianluca MauriFederica TosiKatia BencardinoErica BonazzinaViviana GoriLorenzo RuggieriSabrina ArenaAlberto BardelliSilvia MarsoniSalvatore SienaAndrea Sartore-Bianchi
Published in: Cancers (2022)
oxaliplatin retreatment produced further RR in around one-fifth of patients and DCR 57.8%. Efficacy decreased in more pre-treated patients and around one-third of patients discontinued treatment due to adverse events. Translational studies improving patient selection are warranted.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • ejection fraction
  • prognostic factors
  • squamous cell carcinoma
  • case report
  • replacement therapy
  • case control